结核病点的新兴景观:一种药用化学方法
Baji Baba Shaik1, Kimeshni Moodley1, Safiyah Ghumran1
1Department of Pharmaceutical Chemistry, Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal (Westville), Durban, South Africa.
Medicinal research reviews
|February 7, 2025
概括
抗结核药物发现已经取得了进展,利用基于目标的策略来识别结核病 (TB) 的新线索和候选药物. 持续的研究对于补充药物管道和克服发展挑战至关重要.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 结核病研究 结核病研究
背景情况:
- 在过去十年中,抗结核药物发现取得了重大进展.
- 了解结核病 (TB) 的生物功能,目标抑制和诊断方面的进展.
- 最近对德拉曼尼德和贝达基林的批准突出了治疗多抗药性结核病 (MDR-TB) 和广泛抗药性结核病 (XDR-TB) 的进展.
研究的目的:
- 批判性地分析推进致死化合物的方法,使其成为可行的结核病药物开发的领先候选人.
- 探索新药点对未来结核病治疗策略的潜在影响.
- 识别和讨论在开发新的抗结核药物的当前挑战.
主要方法:
- 基于目标的药物发现技术的审查.
- 在抗肺结核药物开发中优化打击到的策略的分析.
- 检查新目标在应对药物耐药性的作用.
主要成果:
- 基于目标的药物发现是一个强大的工具,用于识别和验证新的目标,线索和候选药物,并提高有效性.
- 结核病药物管道显示发展,但高消耗率需要不断补充高质量的潜在客户.
- 新的目标对未来的药物开发工作充满希望.
结论:
- 尽管取得了进展,但高消耗率仍然是结核病药物开发的挑战.
- 推进打击化合物到主要候选人需要强大的战略.
- 新目标对于维持结核病药物管道和克服耐药性至关重要.
相关概念视频
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Pulmonary Tuberculosis III
299
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
299
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


